NIJHAWAN PARDEEP (Chief Executive Officer) purchased 0.8% of their position (3K shares) of EDESA BIOTECH, INC. on the open market
Open‑market purchase worth $6.3K — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 3/3/2026ACC: 0001171843-26-001302
DirectorOfficer10% Owner· Chief Executive Officer
Since Jun 2019
+3K
Net shares
Net buyer
$6.3K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
3K acquired
Non-Derivative Transactions2
Common Shares
Direct
Shares
+2K
Price / share
$2.00
Trade value
$4K
% of position
0.3%
3/2/2026
625.81K→627.81K
Common Shares
Indirect
Shares
+1K
Price / share
$2.28
Trade value
$2.28K
% of position
0.3%
3/2/2026
371.70K→372.70K
Total
Net shares
+3K
Net value
$6.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 3/2/2026 | P · Purchase | +2K | $2.00 | $4K | 0.3% | 625.81K | 627.81K |
| Common Shares Indirect | 3/2/2026 | P · Purchase | +1K | $2.28 | $2.28K | 0.3% | 371.70K | 372.70K |
| Total | +3K | $6.28K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Shares
IndirectShares owned53.10K
Common Shares
IndirectShares owned32.61K
Common Shares
IndirectShares owned32.01K
Total
117.73K indirect117.73K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 53.10K | Indirect |
| Common Shares | 32.61K | Indirect |
| Common Shares | 32.01K | Indirect |
| Total | 117.73K | 117.73K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported